2,3 Diphosphoglycerate in Parkinson's disease
AUTOR(ES)
Alevizos, B.
RESUMO
The red cell 2,3 DPG, the most important factor for oxygen delivery in the tissues, was found to be increased in Parkinsonism patients compared with controls. The aging process seems not to be a factor in the increased 2,3 DPG concentration. Other factors relevant to raised 2,3 DPG level such as physical activity, increased oxygen requirements, and metabolic changes are discussed.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=492497Documentos Relacionados
- Erythrocyte 2,3-diphosphoglycerate in diabetes and renal disease.
- 2,3-Diphosphoglycerate in acute asthma
- SÃntese e AvaliaÃÃo FarmacolÃgica de O-GlicosÃdeos 2,3 2,3-Insaturados
- Cloning, Sequencing, and Expression of the Gene Encoding Cyclic 2,3-Diphosphoglycerate Synthetase, the Key Enzyme of Cyclic 2,3-Diphosphoglycerate Metabolism in Methanothermus fervidus
- Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration